Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities Conference
Chemomab Therapeutics Ltd. , (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare...
Source: lelezard.com